Related Experiment Video
Updated: Jan 30, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
RCBTB1 Deletion Is Associated with Metastatic Outcome and Contributes to Docetaxel Resistance in
Olivier Mauduit1,2,3, Céline Brulard1,3, Tom Lesluyes1,4
1Inserm U1218, Bergonié Cancer Institute, F-33076 Bordeaux, France.
Abstract:
Half of soft-tissue sarcomas are tumors with complex genomics, which display no specific genetic alterations and respond poorly to treatment. It is therefore necessary to find new therapeutic targets for these sarcomas. Despite genetic heterogeneity across samples, oncogenesis may be driven by common pathway alterations. Therefore, genomic and transcriptomic profiles of 106 sarcomas with complex genomics were analyzed to identify common pathways with altered genes. This brought out a gene belonging to the "cell cycle" biological pathway, RCBTB1 (RCC1 And BTB Domain Containing Protein 1), which is lost and downregulated in 62.5% of metastatic tumors against 34% of non-metastatic tumors. A retrospective study of three sarcoma cohorts revealed that low RCBTB1 expression is prognostic for metastatic progression, specifically in patients that received chemotherapy. In vitro and in vivo, RCBTB1 overexpression in leiomyosarcoma cells specifically sensitized to docetaxel-induced apoptosis. This was associated with increased mitotic rate in vitro and higher growth rate of xenografts. By contrast, RCBTB1 inhibition decreased cell proliferation and protected sarcoma cells from apoptosis induced by docetaxel. Collectively, these data evidenced that RCBTB1 is frequently deleted in sarcomas with complex genomics and that its downregulation is associated with a higher risk of developing metastasis for patients receiving chemotherapy, likely due to their higher resistance to docetaxel.
Insights
RCC1 And BTB Domain Containing Protein 1 (RCBTB1) loss is common in metastatic sarcomas. Low RCBTB1 expression predicts poor chemotherapy response and metastasis in sarcoma patients, highlighting it as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Soft-tissue sarcomas with complex genomics lack specific genetic alterations and are treatment-resistant.
- Identifying novel therapeutic targets is crucial for improving outcomes in these challenging cancers.
Purpose of the Study:
- To identify common molecular pathways and potential therapeutic targets in sarcomas with complex genomics.
- To investigate the role of the cell cycle gene RCBTB1 in sarcoma development and treatment response.
Main Methods:
- Genomic and transcriptomic profiling of 106 sarcomas.
- Retrospective analysis of three sarcoma cohorts.
- In vitro and in vivo functional studies using leiomyosarcoma cells and xenografts.
Main Results:
- RCBTB1 (RCC1 And BTB Domain Containing Protein 1) was identified as frequently lost or downregulated in metastatic sarcomas (62.5%) compared to non-metastatic ones (34%).
- Low RCBTB1 expression correlated with metastatic progression in patients receiving chemotherapy.
- RCBTB1 overexpression sensitized leiomyosarcoma cells to docetaxel, increasing apoptosis and mitotic rate, while inhibition had opposite effects.
Conclusions:
- RCBTB1 deletion and downregulation are frequent in complex genomic sarcomas.
- Reduced RCBTB1 expression is a prognostic marker for chemotherapy resistance and metastatic progression in sarcoma patients.
- RCBTB1 modulates sensitivity to docetaxel, suggesting its potential as a therapeutic target for overcoming treatment resistance.
More Related Videos
Related Concept Videos
Binet's Contribution to Measures of Intelligence
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Wechsler's Contribution to Measures of Intelligence
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Resistivity

